Clinical trial
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis…
NCT00081653 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00081653 |
|---|---|
| Title | A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva |
| Official title | Double-blind, Partially Randomized, Parallel Group, Multicenter Study to Assess the Efficacy and Safety of 100 mg and 150 mg Monthly Oral Ibandronate in Women With Postmenopausal Osteoporosis Having Completed the Phase III Oral Ibandronate Trial BM16549 |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Post-Menopausal Osteoporosis |
| Intervention type | Drug |
| Interventions | ibandronate [Bonviva/Boniva] |
| Enrollment | 719 |
| Start date | May 1, 2004 |
| Primary completion | Nov 1, 2007 |
| Completion | May 1, 2008 |
| First posted | Apr 21, 2004 |
| Last update posted | Jul 14, 2017 |
| Countries | Belgium, Brazil, Czechia, Denmark, France, Germany, Hungary, Italy, Mexico, Norway, Poland, Spain and 2 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: